Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126066912 | 12606691 | 2 | F | 20160808 | 20160729 | 20160820 | EXP | JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-121185 | RANBAXY | OSAWA G, YOSHIMATSU K, YOKOMIZO H, OTANI T, YANO Y, ITAGAKI H, ET AL. A CASE OF MULTIPLE LUNG AND LIVER METASTASES FROM COLON CANCER TREATED WITH CLINICAL BENEFIT BY HEPATIC ARTERIAL INFUSION CHEMOTHERAPY PLUS CETUXIMAB MONO-THERAPY AFTER STANDARD CHEMOTHERAPY FAILURE. GAN-TO-KAGAKU-RYOHO. 2010;37 (12):2526-2528 | 61.00 | YR | F | Y | 0.00000 | 20160820 | OT | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126066912 | 12606691 | 1 | PS | OXALIPLATIN. | OXALIPLATIN | 1 | Unknown | FIRST LINE THERAPY | U | 202922 | |||||||||
| 126066912 | 12606691 | 2 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | U | 202922 | |||||||||||
| 126066912 | 12606691 | 3 | SS | Irinotecan | IRINOTECAN | 1 | Unknown | SECOND LINE THERAPY | U | U | 0 | ||||||||
| 126066912 | 12606691 | 4 | SS | Irinotecan | IRINOTECAN | 1 | Unknown | THIRD LINE THERAPY | U | U | 0 | ||||||||
| 126066912 | 12606691 | 5 | SS | Calcium folinat | LEUCOVORIN CALCIUM | 1 | Unknown | FIRST LINE THERAPY | U | U | 0 | ||||||||
| 126066912 | 12606691 | 6 | SS | Calcium folinat | LEUCOVORIN CALCIUM | 1 | Unknown | THIRD LINE THERAPY | U | U | 0 | ||||||||
| 126066912 | 12606691 | 7 | SS | Bevacizumab | BEVACIZUMAB | 1 | Unknown | FIRST LINE THERAPY | U | U | 0 | ||||||||
| 126066912 | 12606691 | 8 | SS | Bevacizumab | BEVACIZUMAB | 1 | Unknown | SECOND LINE THERAPY | U | U | 0 | ||||||||
| 126066912 | 12606691 | 9 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Unknown | FIRST AND SECOND LINE THERAPY | U | U | 0 | ||||||||
| 126066912 | 12606691 | 10 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | 1000 MG/M2, 1/WEEK | U | U | 0 | 1000 | MG/M**2 | /wk | |||||
| 126066912 | 12606691 | 11 | SS | Cetuximab | CETUXIMAB | 1 | Unknown | THIRD-LINE THERAPY | U | U | 0 | ||||||||
| 126066912 | 12606691 | 12 | SS | Cetuximab | CETUXIMAB | 1 | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126066912 | 12606691 | 1 | Colon cancer |
| 126066912 | 12606691 | 2 | Metastasis |
| 126066912 | 12606691 | 3 | Colon cancer |
| 126066912 | 12606691 | 4 | Metastasis |
| 126066912 | 12606691 | 5 | Colon cancer |
| 126066912 | 12606691 | 6 | Metastasis |
| 126066912 | 12606691 | 7 | Metastasis |
| 126066912 | 12606691 | 8 | Colon cancer |
| 126066912 | 12606691 | 9 | Metastasis |
| 126066912 | 12606691 | 10 | Colon cancer |
| 126066912 | 12606691 | 11 | Metastasis |
| 126066912 | 12606691 | 12 | Colon cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126066912 | 12606691 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126066912 | 12606691 | Anaemia | |
| 126066912 | 12606691 | Disease progression | |
| 126066912 | 12606691 | Malaise | |
| 126066912 | 12606691 | Performance status decreased | |
| 126066912 | 12606691 | Therapeutic response decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126066912 | 12606691 | 1 | 200804 | 0 | ||
| 126066912 | 12606691 | 3 | 200905 | 0 | ||
| 126066912 | 12606691 | 4 | 200908 | 0 | ||
| 126066912 | 12606691 | 5 | 200804 | 0 | ||
| 126066912 | 12606691 | 6 | 200905 | 0 | ||
| 126066912 | 12606691 | 7 | 200804 | 0 | ||
| 126066912 | 12606691 | 8 | 200905 | 0 | ||
| 126066912 | 12606691 | 9 | 200804 | 0 | ||
| 126066912 | 12606691 | 11 | 200908 | 0 |